Non-Classical Therapeutic Approach in the Treatment of Alzheimer's Disease: A Mini Review

  • Bajic V
  • Spremo-Potparevic B
  • Zivkovic L
  • et al.
Citations of this article
Mendeley users who have this article in their library.
Get full text


© 2015 Bentham Science Publishers.Alzheimer's disease (AD) is a multi factorial disease, related to the loss of neurons and synapses in cerebral cortex and subcortical structures, leading to degenerative changes and atrophy. Despite abundance of facts related to AD and its pathology, the only drugs used in the prevention and treatment are those from the cholinesterase inhibitors group. However, there is growing evidence that a non-classical therapeutic approach in the treatment of AD has beneficial effects. In this review we summarized recent literature data related to the non-classical drugs for the treatment of AD predominantly used in clinical testing, such as amyloid aggregation inhibitors, beta-sheet breakers, antioxidants, estrogens and immunotherapeutics




Bajic, V., Spremo-Potparevic, B., Zivkovic, L., Sudar, E., Zafirovic, S., Obradovic, M., & Isenovic, E. (2015). Non-Classical Therapeutic Approach in the Treatment of Alzheimer’s Disease: A Mini Review. Letters in Drug Design & Discovery, 12(2), 158–164.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free